Jubilant Life Sciences on Monday reported a net profit of Rs 5 crore for the first quarter ended June 30, 2012. The net profit declined by 93.50 per cent as compared to Rs 77.12 crore in the corresponding period last year.
The net profit was shown after accounting for unrealised mark-to-market forex loss on loans of Rs 104 crore.
However, the company’s income from operations was up 30.52 per cent at Rs 1,240 crore as compared to Rs 950 crore in the same period last year.
On the NSE, the stock closed today at Rs 171.50, up by Rs 1.30 over yesterday's closing price.